Study backs new bladder cancer recurrence test
This article was originally published in Clinica
Executive Summary
A novel test for bladder cancer recurrence following surgery for the condition has shown promise in an early study. The test assesses the levels of four apoptotic (cell death-causing) proteins associated with the disease's recurrence, in order to give a predictive value for outcomes, according to a study, published in The Lancet Oncology (February).